VALIDATION STRATEGIES FOR MULTI-PRODUCT FACILITIES
|
|
- Moses McKinney
- 6 years ago
- Views:
Transcription
1 VALIDATION STRATEGIES FOR MULTI-PRODUCT FACILITIES By: Justin Roose Head Validation Engineer Product Quality Assurance (Global Compliance) 1
2 Session Agenda 1. Instruction 2. Questions 3. Do it! Open-forum training session Two-way dialog Your experiences 2
3 Group Activities Determine multi-product validation strategies (scenarios) Break into teams Scribe Presenter 3
4 Multiple products or Mixed-use? Session discusses both Concepts are the same Solved by understanding the product and other business lines 4
5 Multiple products or Mixed-use? Very similar product formulae Variety of sunscreen products Same type/business line Variety of oral OTC drugs Mixed-use (cross business-line) Drug/Cosmetic/Supplement/Foods/ Biologics/Device 5
6 Considerations for various business lines Considerations based on regulations inherent to necessary controls Drug Actives, Micro (sanitizing), CPPs, Critical Characteristics Vaccine/Biologics Assay/Actives, Potency, Sterility, Micro (sterilization), CPPs, Critical Characteristics, Environmental conditions 6
7 Considerations for various business lines (con t) Device Verification & Validation, Controls, Consumer Feedback, Safety, Micro (sterilization), Bio Burden, Black/White Box Testing Foods HACCP, Raw Material Controls & Variation, Process Controls, Micro (sanitizing) Supplements Allergens, Therapeutic Ingredients Micro (Sanitation) 7
8 Business Line & Regulations Drive validation approach Regulations what do you think? (list) Many markets accept certifications from comparable or more strict audits Example 8
9 How exactly do we approach validating a mixed-use, or multipleproduct facility? 9
10 First how do we validate a single product What do you think? 10
11 Types of Validation Equipment Cleaning Facilities & Utilities Sanitizing Validation Process & Packaging Laboratory Equipment Test Methods Control & Information Systems Software
12 Validating a mixed-use, or multipleproduct facility Understand your business line requirements (ie. Pharma) Understand the product characteristics and production needs and consider them against other products. Sometimes design for most critical product need or regulation. Simple, but not easy? 12
13 Types of Validation Equipment Cleaning Facilities & Utilities Sanitizing Validation Process & Packaging Laboratory Equipment Test Methods Control & Information Systems Software
14 Questions? Multi-Product Mixed-Use Regulations Product needs Regulatory requirements 14
15 Facility What does the product require? Facility GMP/Sanitary Design Washable surfaces Drainable floors, air gaps to drains Sloped piping Sealing doors Process / Material / People / Waste Flow 15
16 Utilities Clear utility specifications per product requirements (product specifications?) business line requirements Drives the level of validation All critical utilities should be validated 16
17 Utilities Water Quality: RO, DI, WFI, other? Product requirements Validate to specification Tips for Success Design Capacity Consider manufacturing, cleaning and sanitizing needs 17
18 Group Exercise Water System Drugs & cosmetics facility. Water used for cleaning, as a raw material, sanitize rinse. What are the validation requirements for this water system (IOPQ)? Break into teams 3 minutes Scribe (laptop) Presenter 18
19 Group Exercise Water System Share - 1 minutes Team 1 Results? Do you agree? Were your results similar? 19
20 Utilities HVAC Supports product quality Prevents cross-contamination Processing & Storage Air Quality Directional: room to room (ΔP), laminar Temp & Humidity Alarms Dedicated AHUs? 20
21 Class Exercise HVAC Drug facility: Rx, OTCs. Mixing, kinetics, aseptic processing, sterile fill, general filling What are the IOPQ requirements? (list) 21
22 Utilities Steam Capacity & Quality Intended use: Sterilize, Process Heating, Facility? Cleaning & sanitizing Compressed Air (Product requirements) Capacity Quality required for the product Processing, drying 22
23 Other utilities Product Contact Utilities Capacity & Quality (specification) Nitrogen/Hydrogen/Gases Other Support Utilities Dust Collection (Cross contamination) Vacuum Potable water (sanitation, cleaning?) Glycol/Refrigerant/Mineral Oil Cleanser/Sanitizer/Disinfectant 23
24 Warehousing / Storage Raw, Bulk formula, In-process/ Intermediates, Components, Finished Goods, Rejected Material Control Storage limitations - What do you think? Reject, Spatial Separation, Labeling, Controls, Authorizations, Temperature, Humidity, Routine Monitoring Software Systems 24
25 Questions? Product Utilities Support Utilities Warehousing & Storage 25
26 Equipment Design Design & Qualify equipment for a broad range of operations Contact surface Correct materials & finishes Understand equipment capabilities and limitations Types of products it cannot support? 26
27 Equipment Qualification Define your overall IQ / OQ / PQ requirements within the protocol Document intended products within the equipment description section Challenge broad range of capability Provide justification for planned tests Consider equipment train PQs 27
28 Group Exercise Packaging Line Topical Pharma Facility Packaging Line 25 SKUs, different: Bottles & Cap Sizes Emulsions, Oral Suspensions What IQ/OQ tests to perform? Break into teams 3 minutes Scribe (laptop) Presenter 28
29 Group Exercise Water System Share - 1 minutes Team 2 Results? Do you agree? Were your results similar? 29
30 Questions? Production Equipment Qualification 30
31 Process & Packaging Validation Understand each product s needs/cpps Leverage product understanding Access your developmental work Specify process flow & major unit ops Specifications (Acceptance Criteria) Actives, Physiochemical, Micro Batch Size, Order of Additions, Process Steps & CPPs Temps, Speeds, Time, etc 31
32 Product Families What do you think? Product grouping based on similarities: Processing Steps or Addition Order Ingredients Product knowledge is key, leverage your subject matter experts. Small differences can have a big impact be honest about your processes. 32
33 Considerations What similarities allow grouping? Document in protocol Grouping justification Similarities Development / Plant Trial supporting data Demonstrate your product understanding. 33
34 Class Exercise PV Facility: Children's Acetaminophen 1 Strength: 160mg / 5 ml Flavors: Grape, Bubblegum, Cherry Batch Sizes: 500L, 1500L, 3000L What are the PV requirements? # Batches, # of Products? What to test? 34
35 Class Exercise Packaging Facility: Sunscreen Bottle Filling Bottle Sizes: 150mL, 400mL Name Viscosity Active #1 Active #2 Standard 20,000 28,000 cp 15% Avobenzone -- Kids 24,000 30,000 cp 30% Avobenzone 5% TiO 2 Max 30,000 35,000 cp 30% Avovenzone 10% TiO 2 Shimmer 22,000 30,000 cp 8% Avobenzone -- What are the test requirements? # of protocols, # of Products? # of runs? What to test? 35
36 Questions? Process Validation Packaging Validation 36
37 Cleaning Validation Definition: Documented evidence that cleaning process removes product and cleanser to acceptable limits. Cleaning Marker: Analyte(s) used to represent surface cleanliness from the target product. Typically Active Ingredient(s) Could be other ingredients (justification) Allergen 37
38 Cleaning Validation Cleanliness Standards Markers for cleanliness Carryover Limits (this, and other products) Visual Cleanliness (Qualify staff) Dirty Hold Time (DHT Clean Hold Time Value of Process Development, results support selection of cleaning families TACT 38
39 Cleaning Families What do you think? Based on similarities: Actives / Markers Similar ingredients Solubility Difficult to clean compounds Physical properties (drying, viscosity) Coupon studies and development work to classify cleaning families 39
40 Change From Campaigning & Cleaning Matrix Reduce cleaning/sanitizing and changeover (example) Full Clean: Different family Short Clean: Similar product Product flush: Similar product, higher concentration Change To: BP-1 BP-2 BP-3 BP-4 BP-5 BP-1 X WC WC WC WC BP-2 WC X DC DC DC BP-3 WC DC X DC DC BP-4 WC PF DC X DC BP-5 WC DC DC DC X Legend: Wet Clean - WC Product Flush - PF Dry Clean - DC No Clean - X 40
41 Group Exercise Facility: Sunscreen Filling Bottle Sizes: 150mL, 400mL Name Actives Other ingredients Cleanser Family Women s Lotion Octocrylene 15% Fragrance, Color Base (ph 12) E1 Men s Sun Octocrylene 14% Base (ph 12) E1 Moisturizing Ocrocrylene 5% Silicone Base (ph 12) E2 Germ-gone Ethyl Alcohol 70% Gel Water G1 Premium Gel Ethyl Alcohol 70% Gel, Fragrance Water G1 AB Moisturizing Ethyl Alcohol 70% Gel, Vitamin E Water G1 Validation requirements 4 min # of validation protocols? Testing requirements? 41
42 Group Exercise Water System Share - 1 minutes Team 3 Results? Do you agree? Were your results similar? 42
43 Sanitizing/Sterilizing Validation Definition: Documented evidence that sanitizing process reduces microbes to acceptable limits. Standards Sanitizers Microbial Limits Bioburden / Log-reduction Sanitized Hold Time (storage conditions) Single (1) method possible 43
44 Class Exercise Sanitizing Facility: Mixed-Use Bulk Mixing. Medicated Ointment 1000 cfu/100cm 2 Topical Pharmaceutical 1000 cfu/100cm 2 Fish Oil Products (3) 300 cfu/100cm 2 Sanitizing Validation? How many Sanitizing Validations? How many Sanit Processes? 44
45 Questions? Cleaning Validation Sanitizing Validation 45
46 Multi-Product and Mixed-Use Scenarios Classroom Exercises & Tips for Success 46
47 Same Product Family Scenario: Multiple products with the same active ingredient. Hydrocortisone 0.5% 150mL tubes Hydrocortisone 1.5% 150mL tubes Hydrocortisone 0.5% 30mL tubes Hydrocortisone 1.5% 30mL tubes Process Validation Requirements? Packaging Validation Requirements? # of Sanitizing Validations? 47
48 Considerations Same Product Families How similar is the manufacturing process? CPPs / Product specifications Fewer Process & Packaging Validations Likely same equipment utilized (IOPQs) Possibility for bracketing approach 1 worst case cleaning 48
49 Mixed Families Scenario: Multiple families, same business line. Different oral analgesic suspensions Acetaminophen 160mg/5mL Acetaminophen 350mg/5mL Ibuprofen 100mg/5mL Ibuprofen 250mg/5mL PV, Cleaning? Equipment Qualification? 49
50 Considerations Potentially similar equipment Different cleaning requirements, but potentially similar cleaning methods. May be possible to establish one cleaning family Worst case product Likely similar or representative sanitizing 50
51 True mixed-use Scenario: Drugs, Cosmetics & Supplements Different raw material purity requirements Varying cleaning/micro requirements Documentation requirements (such as 2nd person verification, in-process release requirement) What different storage, handling & control requirements? 51
52 Considerations Food/Supplement HACCP requirements needed for food Raw material control and storage is more critical for Supplements Allergen storage limitations Cross contamination Robust sanitizing & environmental monitoring programs 52
53 Ingestible Drug / Nondrug products Many policy & procedures default to drug production for mixed-use. Qualification and Validation only required for drug products. But, consider cleaning for non-drug, carryover risk! Enforce GMPs for all production, or only drug? Pros & Cons? 53
54 Dedicated equipment? Risks: Cleaning / micro, cross-contamination Complicated, time consuming to manage Extreme controls needed Examples: Heart medication (low dosage) Controlled substances Penicillin Kosher / Halal certification 54
55 Questions? Multi-product scenarios Mixed-use scenarios 55
56 Policy & Procedures to support Multi-Product and Mixed-Use Facilities 56
57 Validation Policy Specify the scope of which business lines / products require validation Outline requirements by validation type Facility & Utilities Equipment Qualification Process & Packaging Validation Cleaning & Sanitizing Validation Lab Equipment & Methods Software Validation 57
58 Procedures for Supporting Quality Systems Validation Procedures Quality Manual Master Validation Plan Change Control GMPs & GDPs, Gowning & Access Cleaning, Sanitizing/Sterilization Training 58
59 Session Summary Demonstrate Product / Process knowledge Understand regulation requirements Provide Justification Summarize your validation program for audit compliance and alignment Consider product interactions 59
60 Questions? 60
61 Thank you! Justin B. Roose, Head Validation Engineer Global Compliance, Amway Corp Fulton St. East, Ada MI, Bldg 52-2J Biography Justin Roose Justin is a Lead (Head) Validation Engineer at Nutrilite / Amway Corp in Ada, MI. He is currently leading validation activities in a new 4-phase production facility. His team is responsible for: process, packaging, cleaning, sanitizing and software validation, as well as equipment and utility qualification. His software validation team is also responsible over 25 corporate software systems used to govern GMP functions in North American Operations. Justin received his BS in Chemical Engineering from Calvin College. He has obtained over 15 years of experience, across the pharmaceutical, vaccine, biologics, foods and nutritional supplements fields. Since joining Amway Corp in 2006 Justin has created and implemented an effective change control program, led the Validation Department, and created software & process/packaging validation programs. 61
Guidelines for Process Validation of Pharmaceutical Dosage Forms
Guidelines for Process Validation of Pharmaceutical Dosage Forms Version 2.1 Date issued 21/02/2010 Date of implementation 21/05/2010 31 August 2010 Page 1 of 20 Guidelines for Process Validation of Pharmaceutical
More informationPrequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer
Part 1: General information Name of Manufacturer Production Block Physical address Contact address Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer. Clean Utilities in the Basement.
More informationPreparing Your Aseptic Processing Facility for an FDA Inspection. Valerie Welter, Director Quality Bayer HealthCare March 10, 2014
Preparing Your Aseptic Processing Facility for an FDA Inspection Valerie Welter, Director Quality Bayer HealthCare March 10, 2014 Agenda Regulatory Requirements Establishing your Approach Aseptic Controls
More informationMicrobiological Cleaning Method Validation
Microbiological Cleaning Method Validation The purpose of cleaning procedures should never be to reduce bioburden to an acceptable level! Fergus O Connell QA Manager Eurofins ams Laboratories www.eurofins.com
More informationAseptic Process Validation
Aseptic Process Validation IMB GMP Information Seminar 27 th September 2012 Gerard Sheridan, Inspector Date Insert on Master Slide Slide 1 Overview Guidance Best Practices Common Deficiencies Slide 2 Aseptic
More informationGMP On Site Series. GMP Essentials
GMP On Site Series GMP Essentials GMP Basics Objectives 1. State the critical definitions of the pharmaceutical industry. 2. Describe the law as it applies to various critical functions. 3. State the history
More informationUSP Chapter 823 USP 32 (old) vs. USP 35 (new)
USP Chapter 823 USP 32 (old) vs. USP 35 (new) Sally W. Schwarz, MS, BCNP Research Associate Professor of Radiology Washington University School of Medicine St. Louis, MO Why USP Chapter ? FDA has
More informationPERFORMANCE QUALIFICATION PROTOCOL HVAC SYSTEM
Page 1 of 24 PERFORMANCE QUALIFICATION PROTOCOL FOR HVAC SYSTEM Signing of this Performance Qualification Protocol indicates agreement with the Validation Master Plan approach of the equipment. Further
More informationAnnex Draft Annex
Anmerkung 1: Dieses Vergleichsdokument wurde nach bestem Wissen und Gewissen erstellt und ist rechtlich nicht bindend. Es gelten die von der EMA veröffentlichten Dokumente in der jeweiligen Form. Anmerkung
More informationThe Parenteral Drug Association
C O N F E R E N C E R E P O R T Equipment Cleaning Microbial Control Issues By Destin A. LeBlanc, M.A. Cleaning Validation Technologies Validation: The Parenteral Drug Association (PDA) spring conference
More informationIndustry Perspective on Manufacturing in Early Development
Industry Perspective on Manufacturing in Early Development IQ Workshop, Feb 4-5, 2014, Washington, D.C. Eric Schmitt AbbVie IQ Drug Product Manufacturing Working Group August 2012 issue of Pharmaceutical
More informationWHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer. Mylan Nashik ( Sinnar in CRM) AND
SOP 408.4 Annex D 20, avenue Appia CH-1211 Geneva 27 Switzerland Tel central +41 22 791 2111 Fax central +41 22 791 3111 www.who.int WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer
More informationConducting Supplier Audits: Ensure Validation Compliance
Conducting Supplier Audits: Ensure Validation Compliance Presented by: Gamal Amer, Ph. D. Principal Premier Compliance Services, Inc. All rights reserved. Do not copy without permission. 1 Outline Why
More informationMicrobiological Consideration for Non-Sterile Pharmaceutical
May 1-3, 2012 Javits Center New York, NY Microbiological Consideration for Non-Sterile Pharmaceutical Dr. Leonard W. Mestrandrea Principal Consultant MESTRANDREA CONSULTING LLC Title Date Microbial Control
More informationICH Q8/Q8(R)
Pharmaceutical Quality for the 21 st Century Temple University May 06, 2008 Joseph Famulare, Deputy Director FDA CDER Office of Compliance CDER Office of Compliance and the Critical Path Initiative Since
More informationComparison of Guidelines of Indian GMP with WHO GMP
Comparison of Guidelines of Indian GMP with WHO GMP By Dr. Uma Vasireddy, M.Pharm,Ph.D.., Professor and Principal, KIPS,Wgl, INDIA 1 Outline of Presentation Introductory Elements Section wise Comparison
More informationIntroduction to GMPs and Validation WILLIAM GARVEY AND ASSOCIATES
Introduction to GMPs and Validation WILLIAM GARVEY AND ASSOCIATES William Garvey and Associates LLC 2016 Introduction About your instructor William (Bill) Garvey Important regulations and events Good Manufacturing
More informationReview Validation of aseptic processes for pharmaceuticals
OPEM www.opem.org Oriental Pharmacy and Experimental Medicine 2010 10(4), 231-238 DOI 10.3742/OPEM.2010.10.4.231 Review Validation of aseptic processes for pharmaceuticals Lincy Joseph*, Mathew George
More informationThe Cleaning Validation Process
The Cleaning Validation Process The Scope of Cleaning Validation The Cleaning Validation Sequence Prerequisites Cleaning Validation Strategy, Plan, and Policy Sampling Recovery Studies Analytical Method
More informationValidation Requirements for Nutrition Products
DC1 Validation Requirements for Nutrition Products Supply Division Dimitris Catsoulacos Quality Assurance Specialist UNICEF Supply Division Nutrition Supplier Meeting 14-16 June 2017, Copenhagen Slide
More informationGUIDELINE FOR THE STABILITY TESTING
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 GUIDELINE FOR THE STABILITY TESTING OF NON-PRESCRIPTION (OTC)
More informationPMDA Perspective: Regulatory Updates on Process Validation Standard
CMC Strategy Forum Japan 2014 Tokyo, Japan, December 8-9, 2014 PMDA Perspective: Regulatory Updates on Validation Standard Kazunobu Oyama, PhD Office of Cellular and Tissue-based Products PMDA, Japan Disclaimer:
More informationEnvironmental Monitoring of Aseptic Processing Areas - 1
Environmental Monitoring of Aseptic Processing Areas - 1 A war against an invisible enemy DCVMN - Víctor Maqueda - May 30, 31, June 1 2016 1 Training Course Agenda Overview of Environmental Monitoring
More informationSeamless Integration of ASTM E2500, Annex 15, FDA Process Validation Guideline and Chinese GMP in Large CapEx Project in China Daniel Nilsson
Seamless Integration of ASTM E2500, Annex 15, FDA Process Validation Guideline and Chinese GMP in Large CapEx Project in China Daniel Nilsson Senior Management Consultant Agenda Introduction A state-of
More informationISPE Baseline Pharmaceutical Engineering Guide for New and Renovated Facilities Volume 2: Oral Solid Dosage Forms (Revision) Executive Summary
Reprinted from PHARMACEUTICAL ENGINEERING The Official Magazine of ISPE September/October 2008, Vol. 28 No. 5 This executive summary provides an overview of the second edition of the ISPE Baseline Guide:
More informationSupplier Oversight PQRI. September Steven Lynn, MS, CMQ/OE Vice President Global Quality Compliance Mylan
Supplier Oversight September 2014 PQRI Steven Lynn, MS, CMQ/OE Vice President Global Quality Compliance Mylan Agenda Mylan Background Setting the Stage with a Scenario Current State Thinking Supplier Qualification
More informationPAT & Risk-Based Initiatives: Implementation Issues PDA New England - 8 th Dec Cliff Campbell B.E., C.Eng. CC&A Ltd., Cork, Ireland
PAT & Risk-Based Initiatives: Implementation Issues PDA New England - 8 th Dec 2004 Cliff Campbell B.E., C.Eng. CC&A Ltd., Cork, Ireland cca@iol.ie 1 FDA Context 1) FDA 5-Part Strategic Plan Protect &
More informationEarly Development Best Practices for Stability- Regulatory Perspective
Early Development Best Practices for Stability- Regulatory Perspective IQ Workshop, Feb. 4-5, 2014, Washington, D.C. Ramesh Sood, Ph.D. Division Director (Acting) Office of New Drug Quality Assessment
More informationAnnex 14 WHO guidelines for drafting a site master file 136
World Health Organization WHO Technical Report Series, No.961, 2011 Annex 14 WHO guidelines for drafting a site master file 136 1. Introduction 2. Purpose 3. Scope 4. Content of site master fi le Appendix
More informationCambridge Commodities Ltd QUALITY MATTERS
Cambridge Commodities Ltd QUALITY MATTERS contents Quality at CCL Meet the quality team New supplier and material approvals FTIR investigation Positive release Repack process Regulatory and technical support
More informationPrequalification of Medicines Programme. WHO PUBLIC INSPECTION REPORT (WHOPIR) API Manufacturer
Prequalification of Medicines Programme SOP 408.4 Annex B WHO PUBLIC INSPECTION REPORT API Manufacturer Part 1: General information Name of Manufacturer Unit number WHO PUBLIC INSPECTION REPORT (WHOPIR)
More informationMINIMUM REQUIREMENTS FOR A VENDOR
MINIMUM REQUIREMENTS FOR A VENDOR When outsourcing the production of sterile products the first step in vendor evaluation is to see if they meet the minimum requirements. We ve developed a group of questions
More informationINTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN Review Article
INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Review Article INTRODUCTION AND GENERAL OVERVIEW OF PHARMACEUTICAL PROCESS VALIDATION: A REVIEW Pandita Rachna* 1, Rana A C
More informationINDUSTRIAL PROCESS VALIDATION OF TABLET DOSAGE FORM: A REVIEW
International Journal of Pharmacy Review & Research www.ijprr.com INDUSTRIAL PROCESS VALIDATION OF TABLET DOSAGE FORM: A REVIEW Vishal Sharma* and Nimrata Seth 1 Department of Pharmaceutics, Rayat Institute
More informationEQUIPMENT FOR AUTOCLAVING
EQUIPMENT FOR AUTOCLAVING BY D.NARENDAR M. Pharm-II sem DEPARTMENT OF PHARMACEUTICS UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES KAKATIYA UNIVERSITY, WARANGAL CONTENTS INTRODUCTION ADVANTAGES DISADVANTAGES
More informationAdvancements on implementation of single use technology in vaccine manufacturing
Advancements on implementation of single use technology in vaccine manufacturing October 25 th, 2013 DCVMN Meeting Rio de Janeiro, Brazil Outline Overview of single use products Applications of single
More informationPrequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer
Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer Part 1: General information Name of Manufacturer / Iksan Plant Unit number Production Block Physical address Contact person and email
More informationWHO GUIDELINE Stability testing of active pharmaceutical ingredients and finished pharmaceutical products
WHO GUIDELINE Stability testing of active pharmaceutical ingredients and finished pharmaceutical products 1. Introduction 1.1 Objectives of these guidelines 1.2 Scope of these guidelines 1.3 General principles
More informationInspections, Compliance, Enforcement, and Criminal Investigations
Page 1 of 8 Inspections, Compliance, Enforcement, and Criminal Investigations Lupin Limited 5/7/09 Department of Health and Human Services Public Health Service Food and Drug Administration CENTER FOR
More informationHot Topics in Drug Product Process Validation: A Reviewer s Perspective
Hot Topics in Drug Product Process Validation: A Reviewer s Perspective Colleen Thomas, Ph.D. Quality Assessment Lead (Acting) FDA/CDER/OPQ/OPF Division of Microbiology Assessment CASSS CMC Strategy Forum
More informationCleaning Procedures. These guidelines are intended for Bulk Pharmaceutical Chemicals but almost every word applies to Drug Products
CLEANING DEVELOPMENT Cleaning Procedures as the FDA See It These guidelines are intended for Bulk Pharmaceutical Chemicals but almost every word applies to Drug Products BPC CLEANING (& Drug Products)
More informationManufacturing Optimisation Inside the Pharmaceutical Supply Chain. Business System Compliance
Manufacturing Optimisation Inside the Pharmaceutical Supply Chain. Business System Compliance Bob Mauger, Principal Validation Consultant Cork, April 3/4 2003 Agenda Business System Compliance Overview
More informationCGMP for Phase 1 INDs
CGMP for Phase 1 INDs Laurie P. Norwood Deputy Director Division of Manufacturing and Product Quality Office of Compliance and Biologics Quality Center for Biologics Evaluation and Research 1 Overview
More informationfor IND and RDRC Regulated PET Compounding
Overview of USP Chapter for IND and RDRC Regulated PET Compounding Distributed Manufacturing of PET Radiopharmaceuticals for Multi-Center Clinical Trials SNM, Annual Meeting Toronto, Ontario, Canada
More informationPDA: A Global. Association. Matrix Approach to Media Fills. (c) 2012 Catalent Pharma Solutions. All rights reserved.
PDA: A Global Matrix Approach to Media Fills Association (c) 2012 Catalent Pharma Solutions. All rights reserved. Overview Guidance Overview Matrix Introduction Why Matrix Media Fills Sample Matrix New
More informationValidation. An Easy to Understand Guide Validating Purified Water Systems
Validation Overview Validation Documentation Validation Activities Validation Mistakes Validation Protocols Test Selection Common Verifications When to test Test Layout and Content Validation Protocol
More informationRisk classification guide for drug good manufacturing practices observations GUI-0023
Risk classification guide for drug good manufacturing practices observations GUI-0023 January 18, 2017 Risk classification guide for drug good manufacturing practices observations (GUI-0023) Author: Health
More informationBasics Of Labwasher Cleaning Validation
Basics Of Labwasher Cleaning Validation A Q&A With James Espiritu, Laboratory Equipment Business Applications Manager, Miele Validation is vital to pharmaceutical processes because it assures quality,
More informationHeating, ventilation, and air system encompasses heating, ventilation, and air conditioning, which is integral component of
REVIEW ARTICLE Demand of pharmaceutical facility functionality: Validation and qualification of HVAC system Anamika Singh, Sapna Malviya, Anil Kharia Department of Quality Assurance of Modern Institute
More informationICH Topic M 4 Q Location issues for Common Technical Document for the Registration of Pharmaceuticals for Human Use Quality Questions and Answers
European Medicines Agency August 2003 CPMP/ICH/4680/02 ICH Topic M 4 Q Location issues for Common Technical Document for the Registration of Pharmaceuticals for Human Use Quality Questions and Answers
More informationProduct Permission Document (PPD) of Botulinum Toxin Type A for Injection Ph.Eur Purified Neurotoxin Complex
Product Permission Document (PPD) of Botulinum Toxin Type A for Injection Ph.Eur Purified Neurotoxin Complex Brand Name : BOTO GENIE 1. Introduction : BOTO GENIE (Botulinum Toxin Type A for Injection Ph.Eur)
More informationPage 1
Engineers to Healthcare Industry INTERTECH EQUIPTECHNOLOGIES PVT. LTD. Company Presentation 2014 www.intertechequip.com Page 1 INTERTECH Production facility Total Fabrication Area 75,000 ft2 & Clean room
More informationANNEX V ASEAN GUIDELINES ON STABILITY STUDY AND SHELF-LIFE OF HEALTH SUPPLEMENTS
Association of South East Asian Nations (ASEAN) ANNEX V ASEAN GUIDELINES ON STABILITY STUDY AND SHELF-LIFE OF HEALTH SUPPLEMENTS Disclaimer: This document is provided for information purpose only and subject
More informationAnnex A2. Guidance on Process Validation Scheme for Aseptically Processed Products
Annex A2 Guidance on Process Validation Scheme for Aseptically Processed Products 1 Table of content 1 PURPOSE... 3 2 SCOPE... 3 3 GENERAL INFORMATION... 3 4 INFORMATION NEEDED FOR ASEPTIC PROCESSES VALIDATION...
More informationGUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PART I
PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PE 009-11 (Part I) 1 March 2014 GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PART I PIC/S March 2014 Reproduction
More informationQuality is Our Promise.
Quality is Our Promise. Our goal at KRS Global Biotechnology is to provide the highest quality pharmaceutical preparations. We accomplish this with an unrivaled quality assurance and quality control program
More informationPROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7:NON-STERILE PROCESS VALIDATION
1 Working document QAS/13.527/Rev.2 August 2014 RESTRICTED 2 3 4 5 6 7 8 9 10 PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7:NON-STERILE PROCESS
More informationHealthCaps. Quality our Priority
HealthCaps I N D I A LTD. our Priority Introduction Healthcaps India Ltd is one the largest manufacturers of high quality Empty Capsules worldwide. We are a WHO-GMP, Halal & Kosher certified company in
More informationInitiation of Validation
Initiation of Validation Design Review Who Validates? What Process to Validate? Process Validation Decision Tree When to Validate? Prospective Validation Concurrent Validation Retrospective Validation
More informationEnsuring Quality Pharmacy Compounding: Implications for Pharmaceutics Education
Ensuring Quality Pharmacy Compounding: Implications for Pharmaceutics Education Loyd V. Allen, Jr., Ph.D. Professor & Chair Emeritus University of Oklahoma HSC College of Pharmacy Editor-in in-chief International
More informationGMPs: Distribution Centers
SkillsPlus International Inc. The On-Site Series GMPs: Distribution Centers Learn to apply the GMP regulations as they relate to distribution center operations! FDA Past, Present, and Future and opener
More informationYour partner in the pharmaceutical industry
English Micronisation- and milling service Micronised by GfM Your API Particle size (µm) Your partner in the pharmaceutical industry The... always that little bit finer. We are a family business in the
More informationGuidance for Industry Process Validation: General Principles and Practices. F. Hoffman-La Roche, Ltd.
Guidance for Industry Process Validation: General Principles and Practices D M k T k Dr. Mark Tucker, F. Hoffman-La Roche, Ltd. Disclosures I am currently a Senior Technical Advisor at F. Hoffman -La Roche.
More informationUSP <797> Compliance Common Challenges and Potential Solutions
USP Compliance Common Challenges and Potential Solutions Angela Yaniv, Pharm.D Assistant Director - Sterile Products May 2, 2017 - OSHP Annual Meeting Angela Yaniv has no actual or potential conflict
More informationPIC/S GUIDE TO GOOD PRACTICES FOR THE PREPARATION OF MEDICINAL PRODUCTS IN HEALTHCARE ESTABLISHMENTS
PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PE 010-3 1 October 2008 PIC/S GUIDE TO GOOD PRACTICES FOR THE PREPARATION OF MEDICINAL PRODUCTS IN HEALTHCARE ESTABLISHMENTS
More informationAn Introduction to Double Dragon Consulting
An Introduction to Double Dragon Consulting www.doubledragonconsulting.com 1 June 2012 About DDC Our Experience: All dosage forms, aseptic processes, OTC Remediation of 483 observations, warning letters,
More informationResponding to an FDA 483
Responding to an FDA 483 Jim Melancon VP, Associate General Counsel BioScrip, Inc. Marc Stranz, PharmD Healthcare Consultant Disclosure The speakers declare no conflicts of interest or financial interest
More informationCleaning and Sanitation
Cleaning and Sanitation Training Outcome of the Module: Cleaning and sanitation programs are an important part of GMP, as they protect products from environmental contamination and cross-contamination
More informationLEGAL REQUIREMENTS FOR STABILITY
BY DR. A.V.PRABHU LEGAL REQUIREMENTS FOR STABILITY 21 CFR 211.166- STABILITY TESTING GMP To assess stability characteristics to determine storage conditions and expiration dates. Written stability program
More informationGUIDE TO INSPECTIONS OF STERILE DRUG SUBSTANCE MANUFACTURERS
GUIDE TO INSPECTIONS OF STERILE DRUG SUBSTANCE MANUFACTURERS Note: This document is reference material for investigators and other FDA personnel. The document does not bind FDA, and does no confer any
More informationHosting Inspections from foreign countries: PMDA (Japan) ANVISA (Brazil)
Hosting Inspections from foreign countries: PMDA (Japan) ANVISA (Brazil) Kathrin Abelein Vice President Quality, R-Pharm, JSC First Russian GMP Conference 20. 22. September 2016 Agenda General information
More informationEquipment Qualification Ensure Fit for Intended Use. IVT Amsterdam Conference Mary Sexton. 19 Mar 2015
Equipment Qualification Ensure Fit for Intended Use IVT Amsterdam Conference Mary Sexton 19 Mar 2015 Equipment Qualification Ensure Fit for Intended Use 1. Types of Qualification 2. Validating Equipment
More informationDriving Value through Innovation in Biotech Manufacturing. Agenda
Driving Value through Innovation in Biotech Manufacturing Jorg Thommes, PhD Senior Vice President Operations Technology and Innovation Biogen 7 October 2015 Agenda Biopharma Legacy, Trends, & Challenges
More informationUpdates on Quality Metrics - Industry Perspectives Dan Snider Vice President, Research and Development Mylan Inc.
GPhA/FDA FALL TECHNICAL CONFERENCE Updates on Quality Metrics - Industry Perspectives Dan Snider Vice President, Research and Development Mylan Inc. Disclaimer This presentation contains a summary of the
More informationFDA S GUIDANCE FOR INDUSTRY ANDAS: STABILITY TESTING OF DRUG SUBSTANCES AND PRODUCTS
FDA S GUIDANCE FOR INDUSTRY ANDAS: STABILITY TESTING OF DRUG SUBSTANCES AND PRODUCTS 02-December-2014 San Diego, CA Kim Huynh-Ba Executive Director PHARMALYTIK Kim.huynhba@pharmalytik.com Overview Stability
More informationCompounding Pharmacies and the Contract Testing Lab
Compounding Pharmacies and the Contract Testing Lab Scott Sutton, Ph.D. scott.sutton@microbiol.org 1 Disclaimer I am making this presentation as an independent agent I am not making this presentation as
More informationISO Part 1 and Part 2 Compliance Requirements. Cathriona O Neill
ISO 11607 Part 1 and Part 2 Compliance Requirements Cathriona O Neill I.S. EN 11607 Introduction ISO 11607 is the principal guidance document. Packaging for terminally sterilised medical devices - Part
More informationintegrity and improved efficiency
Kalrez perfluoroelastomer parts for integrity and improved efficiency in pharmaceutical processing Efficiently protecting process integrity is a challenge for all pharmaceutical manufacturers Today s pharmaceutical
More informationTrinity College Dublin QP Forum 2017 Tuesday 25 th April
Trinity College Dublin QP Forum 2017 Tuesday 25 th April HPRA QUESTIONS & ANSWERS 1. What is the approach being taken for audit of contamination control strategies as per chapters 3 & 5? What is the current
More informationPHCT 401 Aseptic Processes & Techniques
PHCT 401 Aseptic Processes & Techniques Principles of Aseptic Techniques Aseptic Processing Sterility Testing Laminar flow air cleaning Quality Control Tests Personnel Principles of Aseptic Techniques
More informationRisk Management in Drug Product Manufacturing with Emphasis on Batch Documentation/Execution
Risk Management in Drug Product Manufacturing with Emphasis on Batch Documentation/Execution Manufacturing Breakout Session I Jack Pellett (Genentech) and Eleni Dokou (Vertex) What are typical lead-times
More informationContamination Risk Assessment in Aseptic, Non-Sterile and Terminally Sterilized Products March 7 th & 8 th Raleigh, NC
Contamination Risk Assessment in Aseptic, Non-Sterile and Terminally Sterilized Products March 7 th & 8 th Raleigh, NC Contamination risk levels differ in aseptic, and non-sterile and terminally sterilized
More informationCritical Environment Products and Services
Critical Environment Products and Services For over two decades, EP Scientific products and services have defined clean for environmental sampling containers and services. Our proprietary cleaning methods
More informationCleaning Validation in a Biologics Facility Case Study. CBE Pty Ltd
Cleaning Validation in a Biologics Facility Case Study CBE Pty Ltd This training program is copyright to CBE Pty Ltd and may not be modified, reproduced, sold, loaned, hired or traded in any form without
More informationA Review article on Pharmaceutical Validation and Process Controls
ISSN: 2277-7695 CODEN Code: PIHNBQ ZDB-Number: 2663038-2 IC Journal No: 7725 Vol. 1 No. 7 2012 Online Available at www.thepharmajournal.com THE PHARMA INNOVATION A Review article on Pharmaceutical Validation
More information18.H Questionnaire for preparing GMP-inspections
Questionnaire for preparing -inspections Questionnaire for preparing -inspections Here you will find answers to the following questions: What questions are typically asked during inspections based on current
More informationGMP MANUAL Contents. Contents (1) 1 Pharmaceutical Quality System (PQS) 2 Personnel
GMP MANUAL GMP MANUAL 1 Pharmaceutical Quality System (PQS) 1.A Preface 1.B The road to a Pharmaceutical Quality System 1.C Introduction to the PQS 1.C.1 General requirements 1.C (1) 1.C.2 Documentation
More informationRegional GMP Strengthening Workshop for Indian Pharmaceutical Manufacturers and State Regulators
Regional GMP Strengthening Workshop for Indian Pharmaceutical Manufacturers and State Regulators Focused on GMP in production of Active Pharmaceutical Ingredients and Oral Solid Dosage Forms Organized
More informationHACCP audit checklist
Requirement HACCP audit checklist Prerequisite Program Management Commitment 1. Senior management ensures that the responsibilities and authorities are defined and communicated within the company Internal
More informationQuestionnaire Layout:
Raw Material Supplier Questionnaire Introduction: This questionnaire has been developed by the EHPM quality working group. It combines work carried out by EHPM various national associations in developing
More informationAPI Stability Protocols and. Chris Byrne Tasmanian Alkaloids
API Stability Protocols and Evaluations Chris Byrne Tasmanian Alkaloids API Stability Overview APIs = 100% pure Limited (if any) degradation No interactions with other agents in drug products Less likelihood
More informationPerformance Testing of Novel Dosage Forms
RQA Ireland Regional Forum - Athlone, May 2016 Quality Considerations Pharma and Biopharma Performance Testing of Novel Dosage Forms Terry Way BPharm MAPS Dissolution Science Consultant Glasside Technologies
More informationActavis Italy. Nerviano Plant
Actavis Italy Nerviano Plant Starting out in 1901 in Jerusalem The company known today as Teva was established as a small wholesale drug business by Chaim Salomon, Moshe Levin and Yitschak Elstein. (They
More informationThe validation of biological Active Pharmaceutical
This article presents a procedure for the validation of biological API manufacturing processes. It details each step of the procedure for biological processes applications, and covers the regulatory requirements
More informationQbD implementation in Generic Industry: Overview and Case-Study
QbD implementation in Generic Industry: Overview and Case-Study Inna Ben-Anat, QbD Strategy Leader, Teva Pharmaceuticals IFPAC JAN 2013 R&D Three Core Components of QbD and Generic Industry: How Do They
More informationGLOBAL QUALITY SOLUTIONS PACKAGE INTEGRITY SEAL INTEGRITY LEAK DETECTION
GLOBAL QUALITY SOLUTIONS PACKAGE INTEGRITY SEAL INTEGRITY LEAK DETECTION Redefining the standards for accuracy and reliability. About PTI PTI Packaging Technologies & Inspection is headquartered in Tuckahoe,
More informationMeeting the challenges of medical device packaging
Meeting the challenges of medical device packaging Gisela Cristina Mendes Bastos Viegas, S.A. October 14, 2011 Agenda Evaluation and selection Validation Test methods Sterile Barrier Systems EN 868 Parts
More informationOn-Site GMP Training GMP COMPLIANCE TECHNICAL
PharmaNet On-Site GMP Training GMP COMPLIANCE TECHNICAL 284 E Lake Mead Pkwy Suite C-278 Henderson, NV 89015 Phone: 702-558-0094 Fax: 702-558-0079 www.gmpseminars.com Key to Level of Program Level A: Program
More informationThe IFSQN FSSC Implementation Package
This is our premiere package for Food Manufacturers looking to achieve certification to FSSC 22000 for Food Safety Management Systems. Food Safety System Certification (FSSC) 22000 is a Global Food Safety
More information